• By Deanna Kamienski, Beth Allan, Amanda Micklus, and Maureen Riordan
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced March through April 2014.
Viking Global is the sole backer in $100mm Series D round for Adaptive Biotechnologies
Adaptive Biotechnologies Corp. (immunosequencing diagnostics) raised $100mm through its Series D round from one backer, Viking Global Investments. The...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
Natco to buy out Adcock Ingram’s minority shareholders in what’s possibly its biggest M&A investment, opening up substantial opportunities in South Africa and the region. If the offer goes through, it will result in the delisting of Adcock, with Bidvest and Natco co-owning the firm.
Scrip discusses the latest M&A activity and trends with CEO Shawn Titcomb of Allele Capital and Cheryl Reicin, a partner focused on international life sciences activity at Mintz.
